Bharat Immunological & Biological Corporation Ltd share price logo

Bharat Immunological & Biological Corporation Ltd

BSE: 524663

Small Cap

Pharma Sector

₹15.25

+0.43

(+2.90%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

What are INDmoney investors doing with Bharat Immunological & Biological shares?

Based on platform-user behaviour - not analyst opinion or company fundamentals.

Search interest on INDmoney

-30%

Searches for Bharat Immunological & Biological on INDmoney have decreased by 30% over the last 30 days.

Bharat Immunological & Biological Stock Performance

as on September 16, 2026 at 8:52 pm IST

  • Day's Low

    Day's High

    ₹14.11
    ₹15.69
    downward going graph

    7.48%

    Downside

    2.89%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹14.10
    ₹22.61
    downward going graph

    7.54%

    Downside

    48.26%

    Upside

    downward going graph

Bharat Immunological & Biological share price movements today

Previous Close
₹14.82
Open
₹15.10
Volume
26.44K
Upper Circuit
₹17.78
Lower Circuit
₹11.86
Day's Low - High
₹14.11 - ₹15.69
52 Week Low - High
₹14.10 - ₹22.61

Bharat Immunological & Biological Historical Returns

1 Month Return
-6.97 %
3 Month Return
-13.49 %
1 Year Return
-33.03 %
3 Year Return
-39.81 %
5 Year Return
-73.75 %

Bharat Immunological & Biological Fundamentals

as on September 16, 2026 at 3:22 pm IST

Market Cap

₹63.99 Cr

Return on Equity (ROE)

0

PE Ratio (TTM)

-3.61

Return on capital employed (ROCE)

0

Industry PE ratio

51.81

Beta (LTM)

0.71

P/B Ratio

-4.09

Dividend Yield

0

PEG Ratio

2.92

Quarterly Earnings Growth YOY

0

EPS (TTM)

0

Book Value

0

Bharat Immunological & Biological Stock Valuation

as on September 16, 2026 at 3:22 pm IST

Bharat Immunological & Biological in the last 5 years

  • Overview

  • Trends

Lowest (-28.17x)

July 13, 2021

Today (-3.61x)

September 11, 2026

Industry (51.81x)

September 11, 2026

Highest (-3.41x)

March 30, 2026

LowHigh

Today’s Price to Earnings Ratio: -3.61x

Bharat Immunological & Biological Technical Analysis

Track how Bharat Immunological & Biological technical analysis has moved over time to understand its trends.

1 min
5 min
15 min
30 min
1 day
1 week
1 month

Technicals Summary

Bearish

Neutral

Bullish

Bullish

Moving Averages

Bearish

Neutral

Bullish

Bullish

Oscillators

Bearish

Neutral

Bullish

Bullish

Overall

Bearish1
Bullish11
Neutral3

Oscillators

Name

Value

Action

MACD level (12,26)
0.03
Bearish
CCI (20)
-381.12
Bullish
RSI (14)
65.41
Neutral
Momentum (10)
0
Neutral
ADI (14)
40.55
Neutral
Ultimate Oscillator (7,14,28)
71.99
Bullish

Moving Averages

Name

Value

Action

SMA (20)
15.24
Bullish
EMA (20)
15.23
Bullish
VWMA (20)
15.25
Bullish
SMA (50)
15.14
Bullish
EMA (50)
15.18
Bullish
SMA (200)
15.1
Bullish
EMA (200)
15.09
Bullish
KAMA (200)
15.24
Bullish
DEMA (200)
15.19
Bullish

Bharat Immunological & Biological Corporation Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Bharat Immunological & Biological with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Bharat Immunological & Biological Corporation Ltd image
Bharat Immunological & Biological Corporation Ltd
NA63.99-14.75%0.00-1844
Bacil Pharma Ltd image
Bacil Pharma Ltd
NA29.1947.69%0.001NA
Concord Biotech Ltd image
Concord Biotech Ltd
BUY15,409.9711.25%0.502591,054
Beryl Drugs Ltd image
Beryl Drugs Ltd
NA11.7921.54%0.00-121
Natco Pharma Ltd image
Natco Pharma Ltd
HOLD14,671.79-3.06%0.541,3714,078
See all

Bharat Immunological & Biological Corporation Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Sep 2023
Other Income
0.16
Total Income
0.16
Expenses
4.69
Operating Profit
-4.69
Profit Before Interest, Tax and Depreciation
-4.52
Interest
2.09
Depreciation
0.03
Profit Before Tax
-6.64
Tax Paid
-1.73
Profit After Tax
-4.92
Total Net profit including share of profit / Loss from associate company
-4.92
EPS
-1.14
Actual EPS
-1.14
Adjusted EPS
-1.14
Diluted EPS
-1.14

Bharat Immunological & Biological Corporation Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Sales
34.8
83.65
66.84
85.33
78.39
44.61
Other Income
1.39
4.22
1.18
1.68
1.1
1.06
Total Income
36.19
87.87
68.02
87.01
79.49
45.67
Expenses
43.01
92.96
77.25
106.21
83.37
60.69
Operating Profit
-8.21
-9.31
-10.41
-20.88
-4.98
-16.08
Operating Profit Margin %
-23.59%
-11.13%
-15.57%
-24.47%
-6.35%
-36.05%
Profit Before Interest, Tax and Depreciation
-6.82
-5.09
-9.22
-19.19
-3.88
-15.02
Interest
0.73
2
4.74
4.78
5.59
7.05
Depreciation
0.41
0.28
0.24
0.24
0.21
0.2
Profit Before Tax
-7.96
-7.37
-14.2
-24.21
-9.68
-22.27
Tax Paid
-3.7
-1.58
-3.99
-6.1
-0.93
-5.63
Profit After Tax
-4.26
-5.79
-10.21
-18.11
-8.75
-16.64
Total Net profit including share of profit / Loss from associate company
-4.26
-5.79
-10.21
-18.11
-8.75
-16.64
EPS
-0.99
-1.57
-2.36
1.1
-2.03
-3.85
Actual EPS
-0.99
-1.57
-2.36
1.1
-2.03
-3.85
Adjusted EPS
-0.99
-1.57
-2.36
1.1
-2.03
-3.85
Diluted EPS
-0.99
-1.57
-2.36
1.1
-2.03
-3.85

Bharat Immunological & Biological Corporation Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Net Cash from Operating Activities
-9.35
-17
2.52
-32.1
34.08
11.78
-42.12
10.89
Cash Flow from Investing Activities
1.35
0.5
-0.84
0.69
0.91
0.67
0.53
0.46
Cash Flow from Financing Activities
-2.13
-3.33
-0.79
30.61
-34.41
-12.21
45
-14.71
Net Cash Flow
-10.12
-19.83
0.89
-0.79
0.58
0.24
3.42
-3.36

Bharat Immunological & Biological Stock Shareholding Pattern

Numbers in percentages

Mar 2024
Promoters
59.25%
Public
40.75%
Total Outstanding Shares
4,31,80,000
Total Shareholders
35,313

Bharat Immunological & Biological Corporate Actions

View detailed summary of the earnings and dividend history of Bharat Immunological & Biological.

  • Bharat Immunological & Biological Corporation Ltd Earnings Results

    Bharat Immunological & Biological Corporation Ltd’s net profit fell -59.74% since last year same period to ₹-4.92Cr in the Q2 2023-2024. On a quarterly growth basis, Bharat Immunological & Biological Corporation Ltd has generated -7.19% fall in its net profits since last 3-months.

    Read More about Earnings Results

Insights on Bharat Immunological & Biological Corporation Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 157.4% return, outperforming this stock by 197.2%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 50.8% return, outperforming this stock by 83.8%

  • imgNO EFFECT

    Retail Holding Unchanged

    img

    Retail Investor holdings remained unchanged at 40.75% of holdings in Mar 2024 quarter

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 59.25% of holdings in Mar 2024 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 years, Bharat Immunolog stock has moved down by -39.8%

About Bharat Immunological & Biological Corporation Ltd

Bharat Immunological and Biological Corporation Limited was incorporated in 1989 in Uttar Pradesh and is in the business of manufacturing pharmaceutical formulations. The company has a manufacturing unit located in Bulandshahr, Uttar Pradesh which is setup to produce 100 million units of the Oral Polio Vaccine (OPV). Commercial production of this vaccine started in January 1996 with orders being received from the Ministry of Health and Family Welfare for interment use in the national immunization programme. Additionally, the Company has a research and development unit whose purpose is to develop the Hepatitis B vaccine via technology transfer from the U.S. To diversify their production, the Company is looking into manufacturing B.C.G., measles, and Tetanus Toxide vaccines. However, the Company has been declared a Sick Company by BIFR (Board for Industrial and Financial Reconstruction).

Revenue: ₹0.00Cr as on September 2023 (Q2 FY24)
Net Profit: ₹-4.92Cr as on September 2023 (Q2 FY24)
Chairperson Name: Y K Gupta
OrganisationBharat Immunological & Biological Corporation Ltd
IndustryPharmaceuticals
CEOY K Gupta
E-voting on sharesClick here to vote

FAQs

What is Bharat Immunological & Biological share price today?

Bharat Immunological & Biological share price today stands at ₹15.25 as on at the close of the market. Bharat Immunological & Biological share today touched a day high of ₹15.69 and a low of ₹14.11.

What is the 52 week high and 52 week low range for Bharat Immunological & Biological share?

Bharat Immunological & Biological touched a 52 week high of ₹22.61 and a 52 week low of ₹14.1. Bharat Immunological & Biological share price today i.e. is closed at ₹15.25, which is -32.55% down from its 52 week high and 8.16% up from its 52 week low.

What is Bharat Immunological & Biological's market capitalisation today?

Bharat Immunological & Biological market capitalisation is ₹63.99 Cr as on .

How to buy Bharat Immunological & Biological shares?

To buy Bharat Immunological & Biological shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for 524663 or Bharat Immunological & Biological Corporation Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Bharat Immunological & Biological shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Bharat Immunological & Biological trading volume today?

Bharat Immunological & Biological trading volume is 26.44K as on . This means that 26.44K shares of Bharat Immunological & Biological were bought and sold on the stock market during today's trading session.